iBio to Participate in Upcoming Investor Conferences

Company Overview - iBio, Inc. is an AI-driven innovator focused on precision antibody therapies, developing biopharmaceuticals for cardiometabolic diseases, obesity, cancer, and other challenging conditions [4] - The company utilizes proprietary 3D modeling and advanced computational biology to create a pipeline of breakthrough antibody treatments aimed at addressing significant unmet medical needs [4] Upcoming Events - Martin Brenner, DVM, Ph.D., CEO and Chief Scientific Officer, and Felipe Duran, CFO, will participate in fireside chats at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 26, 2026, at 2:00 p.m. ET [2][3] - They will also attend the Leerink Global Healthcare Conference on March 9, 2026, at 4:20 p.m. ET, held in Miami, FL [3] - One-on-one meetings with Dr. Brenner and Mr. Duran will be available during both conferences [3] Access to Information - Livestreams of both events will be accessible, and replays will be available on the Investor section of the iBio website for 90 days post-event [3]